GW&K Investment Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.5M | Sell |
481,288
-20,923
| -4% | -$761K | 0.16% | 215 |
|
|
2025
Q1 | $18.2M | Sell |
502,211
-7,334
| -1% | -$266K | 0.17% | 210 |
|
|
2024
Q4 | $21.4M | Buy |
509,545
+42,976
| +9% | +$1.81M | 0.18% | 199 |
|
|
2024
Q3 | $25.9M | Buy |
466,569
+60,050
| +15% | +$3.34M | 0.22% | 182 |
|
|
2024
Q2 | $16.7M | Buy |
406,519
+103,142
| +34% | +$4.24M | 0.15% | 213 |
|
|
2024
Q1 | $14.2M | Sell |
303,377
-4,152
| -1% | -$194K | 0.12% | 225 |
|
|
2023
Q4 | $14.7M | Sell |
307,529
-3,386
| -1% | -$162K | 0.14% | 210 |
|
|
2023
Q3 | $11.1M | Buy |
310,915
+24,444
| +9% | +$871K | 0.11% | 230 |
|
|
2023
Q2 | $13.2M | Buy |
286,471
+223,157
| +352% | +$10.3M | 0.13% | 211 |
|
|
2023
Q1 | $2.54M | Buy |
+63,314
| New | +$2.54M | 0.02% | 297 |
|